5.045
Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
13.97%
52.44
|
46.01 | 80.54 | 47.08 | 43.77 |
Cost Of Revenue |
16.53%
12.30
|
10.56 | 29.10 | 10.66 | 10.73 |
Gross Profit |
13.21%
40.13
|
35.45 | 51.45 | 36.42 | 33.04 |
|
6.46%
33.50
|
31.47 | 29.37 | 38.60 | 35.34 |
Benefits Costs and Expenses |
8.26%
46.27
|
42.74 | 59.93 | 51.23 | 48.36 |
Costs And Expenses |
8.99%
45.80
|
42.02 | 58.46 | 49.26 | 46.06 |
Depreciation and Amortization |
1.18%
2.763
|
2.796 | 2.878 | 2.908 | 2.897 |
Operating Income/Loss |
66.57%
6.636
|
3.984 | 22.08 | -2.179 | -2.299 |
Nonoperating Income/Loss |
34.31%
-0.471
|
-0.717 | -1.471 | -1.972 | -2.296 |
Income/Loss From Continuing Operations Before Tax |
88.71%
6.165
|
3.267 | 20.61 | -4.151 | -4.595 |
Income Tax Expense/Benefit, Current |
5.80%
0.31
|
0.293 | - | - | - |
Income Tax Expense/Benefit |
5.80%
0.31
|
0.293 | 0.291 | 0.378 | 0.22 |
Income/Loss From Continuing Operations After Tax |
96.87%
5.855
|
2.974 | 20.32 | -4.529 | -4.815 |
|
96.87%
5.855
|
2.974 | 20.32 | -4.529 | -4.815 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.21%
49.70
|
49.60 | 49.01 | 48.29 | 48.19 |
Diluted Average Shares |
0.48%
50.14
|
49.91 | 49.17 | 48.29 | 48.19 |
Basic Earnings Per Share |
100.00%
0.12
|
0.06 | 0.41 | -0.09 | -0.10 |
Diluted Earnings Per Share |
100.00%
0.12
|
0.06 | 0.41 | -0.09 | -0.10 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):